NCT05684770

Impact of Remote Care in Patients Diagnosed With Thromboembolic Disease of Low Risk

Evaluation of Feasibility and Impact of Remote Care in Patients With Thromboembolic Disease of Low Risk

• Status: Recruiting
• Phase: N/A
• Study type: Interventional
• Enrollment: 50 (estimated)
• Sponsor: Centre Hospitalier Eure-Seine · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The goal of this clinical trial is to learn about the feasibility and impact of remote care in patients diagnosed with thromboembolic disease of low risk. The main questions it aims to answer are: * the evaluation of feasibility of organisation between different healthcare professionals (hospital physicians, primary care physician) at 6 months and 1 year * the evaluation of complication rate, hospitalisation related to thromboembolic disease rate, compliance to treatment rate at 6 months and 1 year Participants will receive indication of treatment according to national recommendations. Additionnally, they will receive for the length of study a 4G tablet in order to fill questionnaires, learn information about their drugs (patient education), have a remote consultation and evaluate treatment compliance.

Conditions

• Thromboembolic Disease

Interventions

Type	Name	Description
OTHER	4G tablet	Participants will receive for the whole period of study a 4G tablet in order to fill questionnaires, learn information about their drugs (patient education), have a remote consultation and evaluate treatment compliance.

Timeline

• Start date: 2025-09-01
• Primary completion: 2027-03-01
• Completion: 2028-03-01
• First posted: 2023-01-13
• Last updated: 2025-09-15

Locations

1 site across 1 country: France